Search results
Acadia's (ACAD) Nuplazid Sales Drive Growth Amid Competition
Zacks via Yahoo Finance· 6 months agoAcadia (ACAD) is witnessing robust growth in revenues, driven by Nuplazid and Daybue sales. However,...
Here's Why You Should Add Acadia (ACAD) Stock to Your Portfolio
Zacks via Yahoo Finance· 1 year agoAcadia (ACAD), a top-ranked stock at present, is witnessing steady growth in Nuplazid sales since...
Acadia (ACAD) Thrives on Nuplazid, Overdependence a Concern
Zacks via Yahoo Finance· 2 years agoAcadia's (ACAD) lead drug, Nuplazid, is approved for treating hallucinations and delusions...
Acadia (ACAD) Rises 35% on Positive Patent Ruling for Nuplazid
Zacks via Yahoo Finance· 6 months agoAcadia (ACAD) announces a ruling from the U.S. District Court in Delaware, strongly in favor of the...
Reasons to Add Acadia (ACAD) Stock to Your Portfolio Now
Zacks via Yahoo Finance· 8 months agoSan Diego, CA-based Acadia Pharmaceuticals Inc. ACAD is a commercial biopharmaceutical company...
Acadia Soars To A Four-Month High After Winning A Patent Battle For Its Biggest Drug
Investor's Business Daily· 6 months agoAcadia Pharmaceuticals notched a win in a patent battle Wednesday pertaining to its Parkinson's...
Acadia Hits 11-Month Low After Outsized Placebo Effect Torpedoes Schizophrenia Study
Investor's Business Daily· 3 months agoAcadia stock crashed to an 11-month low Tuesday after an outsized placebo effect torpedoed the...
ACADIA Pharmaceuticals Inc. Reports Record Revenues in Q3 2023
GuruFocus.com via Yahoo Finance· 7 months agoACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) reported record revenues in Q3 2023, driven by the strong...
FDA Panel Votes Against Acadia (ACAD) sNDA for Nuplazid
Zacks via Yahoo Finance· 2 years agoAn FDA advisory committee votes against Acadia's (ACAD) Nuplazid (pimavanserin) for treating...
Acadia (ACAD) Q4 Earnings Miss, Nuplazid Sales Boost Revenues
Zacks via Yahoo Finance· 1 year agoAcadia Pharmaceuticals (ACAD) reports mixed results for the fourth quarter of 2022, recording...